Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124452032 | 12445203 | 2 | F | 2016 | 20160729 | 20160607 | 20160803 | PER | US-CELGENEUS-USA-2016047484 | CELGENE | 0.00 | M | Y | 75.82000 | KG | 20160803 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124452032 | 12445203 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | N | U | B2005AA | 20785 | 200 | MG | CAPSULES | QD | ||||
| 124452032 | 12445203 | 2 | SS | THALOMID | THALIDOMIDE | 1 | Oral | 100-150 MG | N | U | B2005AA | 20785 | CAPSULES | QD | |||||
| 124452032 | 12445203 | 3 | SS | THALOMID | THALIDOMIDE | 1 | Oral | 200-100 MG | N | U | B2005AA | 20785 | CAPSULES | QD | |||||
| 124452032 | 12445203 | 4 | SS | THALOMID | THALIDOMIDE | 1 | Oral | 400-100 MG | N | U | B2005AA | 20785 | CAPSULES | QD | |||||
| 124452032 | 12445203 | 5 | SS | THALOMID | THALIDOMIDE | 1 | Oral | N | U | B2005AA | 20785 | 100 | MG | CAPSULES | |||||
| 124452032 | 12445203 | 6 | C | ZANAFLEX | TIZANIDINE HYDROCHLORIDE | 1 | Unknown | 0 | 4 | MG | UNKNOWN | TID | |||||||
| 124452032 | 12445203 | 7 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Unknown | 90 MILLIGRAM | 0 | 10 | MG | UNKNOWN | |||||||
| 124452032 | 12445203 | 8 | C | VALIUM | DIAZEPAM | 1 | Unknown | 4000 MILLIGRAM | 0 | 10 | MG | UNKNOWN | BID | ||||||
| 124452032 | 12445203 | 9 | C | FENTANYL. | FENTANYL | 1 | Unknown | 0 | 50 | UG | POULTICE OR PATCH | ||||||||
| 124452032 | 12445203 | 10 | C | FENTANYL. | FENTANYL | 1 | Unknown | 0 | 100 | UG | POULTICE OR PATCH | ||||||||
| 124452032 | 12445203 | 11 | C | FENTANYL. | FENTANYL | 1 | Unknown | 0 | 75 | UG | POULTICE OR PATCH | QOD | |||||||
| 124452032 | 12445203 | 12 | C | Oxycodone | OXYCODONE | 1 | Unknown | 0 | 30 | MG | UNKNOWN | TID | |||||||
| 124452032 | 12445203 | 13 | C | NEURONTIN | GABAPENTIN | 1 | Unknown | 0 | 1000 | MG | UNKNOWN | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124452032 | 12445203 | 1 | Plasma cell myeloma |
| 124452032 | 12445203 | 2 | Plasma cell myeloma |
| 124452032 | 12445203 | 6 | Product used for unknown indication |
| 124452032 | 12445203 | 7 | Product used for unknown indication |
| 124452032 | 12445203 | 8 | Product used for unknown indication |
| 124452032 | 12445203 | 9 | Pain |
| 124452032 | 12445203 | 12 | Product used for unknown indication |
| 124452032 | 12445203 | 13 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124452032 | 12445203 | Arthralgia | |
| 124452032 | 12445203 | Bone disorder | |
| 124452032 | 12445203 | Depression | |
| 124452032 | 12445203 | Hypoaesthesia | |
| 124452032 | 12445203 | Musculoskeletal pain | |
| 124452032 | 12445203 | Neuropathy peripheral | |
| 124452032 | 12445203 | Pain in extremity | |
| 124452032 | 12445203 | Paraesthesia | |
| 124452032 | 12445203 | Tearfulness | |
| 124452032 | 12445203 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124452032 | 12445203 | 1 | 200501 | 0 | ||
| 124452032 | 12445203 | 2 | 200604 | 0 | ||
| 124452032 | 12445203 | 3 | 200612 | 0 | ||
| 124452032 | 12445203 | 4 | 201102 | 0 | ||
| 124452032 | 12445203 | 5 | 20120601 | 20160601 | 0 |